We’re thrilled to honor the recipients of the 2023 Vivli Antimicrobial Resistance Surveillance Open Data Re-Use Data Challenge, generously sponsored by Wellcome. At a special gathering during ESCMID 2024 in Barcelona, teams presented their solutions, showcasing the transformative potential of data re-use in addressing global health challenges like antimicrobial resistance.
“At Vivli, our dedication to healthcare innovation is unwavering,” said Rebecca Li, Vivli CEO. “The innovations unveiled at the 2023 Vivli AMR Surveillance Data Challenge underscore the vital role of collaboration and data-driven strategies in the fight against antimicrobial resistance. Together, we’re shaping the future of global health.
As a scientist, it was gratifying to meet with the winners of the challenge and hear more about their innovative solutions and findings from their analysis of the pharmaceutical surveillance data. Our heartfelt gratitude goes to Wellcome for their invaluable support, and to our data contributors and all participants who played a pivotal role in this challenge.”
The Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome was designed to foster awareness and incentivize the repurposing of surveillance data available in the AMR Register. Attracting 56 teams from 28 nations, this event served as a catalyst for cross-disciplinary collaboration and empowered participants to leverage the wealth of high-quality AMR surveillance data generously contributed by GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, and Venatorx.
